[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE9003100D0 - Lipid formulation system - Google Patents

Lipid formulation system

Info

Publication number
SE9003100D0
SE9003100D0 SE9003100A SE9003100A SE9003100D0 SE 9003100 D0 SE9003100 D0 SE 9003100D0 SE 9003100 A SE9003100 A SE 9003100A SE 9003100 A SE9003100 A SE 9003100A SE 9003100 D0 SE9003100 D0 SE 9003100D0
Authority
SE
Sweden
Prior art keywords
lipid
matrix
particle forming
lipid particle
forming matrix
Prior art date
Application number
SE9003100A
Other languages
English (en)
Inventor
M Nicklasson
Original Assignee
Kabivitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabivitrum Ab filed Critical Kabivitrum Ab
Priority to SE9003100A priority Critical patent/SE9003100D0/sv
Publication of SE9003100D0 publication Critical patent/SE9003100D0/sv
Priority to IE324691A priority patent/IE62194B1/en
Priority to CA002069760A priority patent/CA2069760C/en
Priority to ES91919389T priority patent/ES2088024T3/es
Priority to DE69119400T priority patent/DE69119400T2/de
Priority to AT91919389T priority patent/ATE137667T1/de
Priority to PCT/SE1991/000639 priority patent/WO1992005771A1/en
Priority to EP91919389A priority patent/EP0514506B1/en
Priority to AU87105/91A priority patent/AU645143B2/en
Priority to JP3516564A priority patent/JP2855594B2/ja
Priority to DK91919389.6T priority patent/DK0514506T3/da
Priority to PT99113A priority patent/PT99113B/pt
Priority to NO921231A priority patent/NO304729B1/no
Priority to FI922452A priority patent/FI107696B/sv
Priority to US08/242,054 priority patent/US5665379A/en
Priority to GR960402032T priority patent/GR3020674T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Colloid Chemistry (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Saccharide Compounds (AREA)
  • Fertilizers (AREA)
SE9003100A 1990-09-28 1990-09-28 Lipid formulation system SE9003100D0 (sv)

Priority Applications (16)

Application Number Priority Date Filing Date Title
SE9003100A SE9003100D0 (sv) 1990-09-28 1990-09-28 Lipid formulation system
IE324691A IE62194B1 (en) 1990-09-28 1991-09-13 Lipid formulation systems
DK91919389.6T DK0514506T3 (da) 1990-09-28 1991-09-24 Lipid-formuleringssystem
PCT/SE1991/000639 WO1992005771A1 (en) 1990-09-28 1991-09-24 Lipid formulation system
JP3516564A JP2855594B2 (ja) 1990-09-28 1991-09-24 脂質粒子形成マトリックス及びその製造方法
DE69119400T DE69119400T2 (de) 1990-09-28 1991-09-24 System auf basis einer lipidformulierung
AT91919389T ATE137667T1 (de) 1990-09-28 1991-09-24 System auf basis einer lipidformulierung
CA002069760A CA2069760C (en) 1990-09-28 1991-09-24 Lipid formulation system
EP91919389A EP0514506B1 (en) 1990-09-28 1991-09-24 Lipid formulation system
AU87105/91A AU645143B2 (en) 1990-09-28 1991-09-24 Lipid formulation system
ES91919389T ES2088024T3 (es) 1990-09-28 1991-09-24 Sistema de formulacion de lipidos.
PT99113A PT99113B (pt) 1990-09-28 1991-09-27 Processo para a preparacao de matrizes que originam particulas de lipidos
NO921231A NO304729B1 (no) 1990-09-28 1992-05-26 Lipidpartikkeldannende matriks
FI922452A FI107696B (sv) 1990-09-28 1992-05-27 Lipidpartikelbildande matris och förfarande för dess framställning
US08/242,054 US5665379A (en) 1990-09-28 1994-05-13 Lipid particle forming matrix, preparation and use thereof
GR960402032T GR3020674T3 (en) 1990-09-28 1996-07-31 Lipid formulation system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003100A SE9003100D0 (sv) 1990-09-28 1990-09-28 Lipid formulation system

Publications (1)

Publication Number Publication Date
SE9003100D0 true SE9003100D0 (sv) 1990-09-28

Family

ID=20380490

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9003100A SE9003100D0 (sv) 1990-09-28 1990-09-28 Lipid formulation system

Country Status (15)

Country Link
EP (1) EP0514506B1 (sv)
JP (1) JP2855594B2 (sv)
AT (1) ATE137667T1 (sv)
AU (1) AU645143B2 (sv)
CA (1) CA2069760C (sv)
DE (1) DE69119400T2 (sv)
DK (1) DK0514506T3 (sv)
ES (1) ES2088024T3 (sv)
FI (1) FI107696B (sv)
GR (1) GR3020674T3 (sv)
IE (1) IE62194B1 (sv)
NO (1) NO304729B1 (sv)
PT (1) PT99113B (sv)
SE (1) SE9003100D0 (sv)
WO (1) WO1992005771A1 (sv)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260065A (en) * 1991-09-17 1993-11-09 Micro Vesicular Systems, Inc. Blended lipid vesicles
SE9200952D0 (sv) * 1992-03-27 1992-03-27 Kabi Pharmacia Ab Pharmaceutical carrier system containing defined lipids
SE9200951D0 (sv) * 1992-03-27 1992-03-27 Kabi Pharmacia Ab Pharmaceutical composition containing a defined lipid system
US5716639A (en) * 1994-02-04 1998-02-10 Scotia Lipidteknik Ab Lipophilic carrier preparations
DE4447287C1 (de) * 1994-12-30 1996-11-07 Cevc Gregor Präparat zum Wirkstofftransport durch Barrieren
SE9703691D0 (sv) 1997-10-10 1997-10-10 Astra Ab Pharmaceutical compositions
GB2344520A (en) * 1998-12-08 2000-06-14 Phares Pharm Res Nv Pharmaceutical carriers comprising lipids and polymers
EP1140021B1 (en) 1998-12-23 2004-08-04 Idea Ag Improved formulation for topical non-invasive application in vivo
SE0000730D0 (sv) * 2000-03-06 2000-03-06 Scotia Holdings Plc Lipid carrier
SE0200475D0 (sv) * 2002-02-15 2002-02-15 Ltp Lipid Technologies Provide Oral farmaceutisk beredning
SE0201922D0 (sv) 2002-06-20 2002-06-20 Ltp Lipid Technologies Provide Koagulationshindrande komposition (Anticoagulant Composition)
FR2868704B1 (fr) * 2004-04-07 2007-09-14 Ethypharm Sa Utilisation de lipides pour ameliorer la biodisponibilite de principes actifs proteiques en formulations injectables sous cutanees ou intra-musculaires
EP1742663A2 (en) 2004-04-15 2007-01-17 Chiasma, Ltd. Compositions capable of facilitating penetration across a biological barrier
US20090041829A1 (en) * 2005-04-28 2009-02-12 Galenica Technology Ab Pharmaceutical dosage forms comprising a lipid phase
JP5362360B2 (ja) * 2005-10-11 2013-12-11 イッサム リサーチ ディヴェロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム 経鼻投与用組成物
MX348705B (es) 2008-09-17 2017-06-26 Chiasma Inc Composiciones farmacéuticas y métodos de administración relacionados.
CN101926757B (zh) 2010-09-01 2013-01-02 北京大学 一种难溶性药物的液体组合物及其制备方法
EP3253401A4 (en) 2015-02-03 2018-11-21 Chiasma Inc. Method of treating diseases
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods
CN117580560A (zh) * 2021-05-03 2024-02-20 Mcal治疗公司 微粉化脂质

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT8219012A0 (it) * 1982-01-06 1982-01-06 Ausonia Farma Srl Metodo per la somministrazione orale di sostanze sotto forma di liposomi, e relative formulazioni farmaceutiche.
DE3585967D1 (de) * 1984-03-08 1992-06-11 Phares Pharma Holland Liposombildende zusammensetzung.
GB8613811D0 (en) * 1986-06-06 1986-07-09 Phares Pharm Res Nv Composition & method
US4610868A (en) * 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
SE8603812D0 (sv) * 1986-09-12 1986-09-12 Draco Ab Administration of liposomes to mammals
NO177774C (no) * 1987-01-27 1995-11-22 Vestar Inc Fremgangsmåte for fremstilling av et preparat egnet for tilförsel av en hovedsakelig vannuopplöslig aktiv bestanddel

Also Published As

Publication number Publication date
NO922084D0 (no) 1992-05-26
JPH05503711A (ja) 1993-06-17
FI922452A (fi) 1992-05-27
AU8710591A (en) 1992-04-28
PT99113A (pt) 1992-08-31
NO304729B1 (no) 1999-02-08
ATE137667T1 (de) 1996-05-15
CA2069760A1 (en) 1992-03-29
DE69119400D1 (de) 1996-06-13
IE913246A1 (en) 1992-04-08
FI107696B (sv) 2001-09-28
FI922452A0 (fi) 1992-05-27
JP2855594B2 (ja) 1999-02-10
GR3020674T3 (en) 1996-10-31
EP0514506A1 (en) 1992-11-25
DE69119400T2 (de) 1996-12-05
PT99113B (pt) 1999-02-26
ES2088024T3 (es) 1996-08-01
NO922084L (no) 1992-05-26
EP0514506B1 (en) 1996-05-08
WO1992005771A1 (en) 1992-04-16
AU645143B2 (en) 1994-01-06
DK0514506T3 (da) 1996-08-12
IE62194B1 (en) 1994-12-28
CA2069760C (en) 1998-02-10

Similar Documents

Publication Publication Date Title
DK0514506T3 (da) Lipid-formuleringssystem
DE3681755D1 (de) Wirkstofftraeger und diesen enthaltende arzneimittel.
DK233080A (da) Overtraeksmiddel til foedevarer og medicinalvarer fremgangsmaade til fremstilling deraf samt produkter forsynet med et saadant overtraek
DE68920394D1 (de) Heterozyklische Verbindungen und Arzneimittel, die die Wirkung von Antikrebsmitteln verstärken, welche diese als wirksame Bestandteile enthalten.
MC1119A1 (fr) Derives de l'isoquinoleine,leur preparation et medicaments contenant ces substances
AR011080A1 (es) Composicion en polvo seco, proceso para su preparacion y uso de dicha composicion para la fabricacion del medicamento
HUT70150A (en) Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines, pharmaceutical compositions containing them and method for its preparation
KR900005990A (ko) 차전자(psyllium)-함유 생성물
ES2058988T3 (es) Preparacion de medicamentos para el tratamiento sistemico de peces ornamentales y utiles.
Khan et al. Development of microencapsulation: A review of literature
NO933323D0 (no) Naerings- og medikamentblandinger paa basis av kitosan for administrering til droevtyggere
IL82523A0 (en) Microbicidal compositions,their manufacture and drugs containing them
FI960688A (sv) Substituerade bensensulfonylureor och -tioureor, förfarande för deras framställning och användning av farmaceutiska produkter som baserar sig på dessa föreningar samt läkemedel som innehåller dessa
JPS61178914A (ja) ヒト及び動物の耳への局所投与用不溶性薬剤
FR2676648B1 (fr) Nouvelles compositions, leur procede de preparation et leurs applications comme substance active de medicament antigrippal ou antiviral.
BE862053A (fr) Peptides contenant de la phenylglycine utiles comme medicaments, procede pour leur preparation et compositions pharmaceutiques en contenant
BE874154A (fr) Derives de l'eburnamonine, leur preparation et medicaments contenant ces substances
KR100486794B1 (ko) 다른 상 운반체 사이에서 하나 또는 그 이상의 활성인자를 이동시키는 방법
Food and Drug Administration, HHS Ingrown toenail relief drug products for over-the-counter human use. Final rule
KR960033455A (ko) 항암조성물
FR2690159B1 (fr) Derives d'acide 3,4-dihydro-2h-1,2,4-benzothiadiazine 1,1-dioxyde-3-carboxylique, leur preparation et les medicaments les contenant.
KR920016104A (ko) 노인성 특발적 백내장 약제 제조를 위한 칼시토닌의 국소적용 용도 및 이의 약제학적 조성물
TH13351A (th) สารประกอบ
NL180479C (nl) Werkwijze voor de bereiding of vervaardiging van geneesmiddelen met ontstekingsremmende en corticoide activiteit, gevormde geneesmiddelen alsmede werkwijze voor de bereiding van 1,4-pregnadieenverbindingen, geschikt voor het gebruik als werkzame stof in deze geneesmiddelen.
TH24542A (th) อนุพันธ์ของกรด 8-ออกโซ -5, 8 - ไอไฮโดร-6H-ไดเบนโซ [a,g] ควิโนลิซีน-13-โพรพาโนอิก วิธีการเตรียมอนุพันธ์ของกรดนี้และการใช้ประโยชน์ของอนุพันธ์เหล่านี้ในทางบำบัดรักษา